Dr. Marina G. Silveira, MD

Dr. Silveira practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Silveira's NPI, 1831163526, was assigned on February 17, 2006. Dr. Silveira holds Minnesota license 47776.

Dr. Silveira's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Silveira's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. Dr. Silveira is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Silveira to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silveira practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Silveira's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Silveira's licenses on file in 2 states: Minnesota and Connecticut.

CMS data shows 117 Medicare services from Dr. Silveira across 3 procedure codes in 2024, all of them office visits, for 129 Medicare patients. Medicare paid $12,098 for them. Every service was in an office.

CMS counts 129 Medicare patients who saw Dr. Silveira in 2024. The largest group is 65 to 74, with 62 patients. 71% of them have high cholesterol, and 67% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silveira's median patient age at 64, with 62% women.

In 2024, Dr. Silveira wrote 462 Medicare Part D claims for 99 patients. 94% of them were for generic drugs. CMS names the drug for 384 of them, across 10 drugs with 11 or more claims each, at $87,430 in total drug cost. In 2023, CMS named 286 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Silveira for performance year 2024, reported as part of a group. Dr. Silveira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silveira as offering telehealth. CMS counts 13 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Silveira, more than 45% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Silveira, published from 2011 to 2023. 2011 was the busiest year, with 3. The most frequent topics are Liver Cirrhosis, Biliary, Cholagogues and Choleretics and Ursodeoxycholic Acid. Dr. Silveira has published most often in Hepatology. Dr. Silveira's most frequent co-authors are Ahmad Hassan Ali, MD, James Lorenzen Boyer, MD and Costica Aloman, MD.

Dmand AI links Dr. Silveira to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Liver Cirrhosis, Biliary, Cholestasis, Intrahepatic and Cholangitis, Sclerosing.